Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001645469-17-000002
Filing Date
2017-03-28
Accepted
2017-03-28 13:39:28
Documents
1
Effectiveness Date
2017-03-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7503
  Complete submission text file 0001645469-17-000002.txt   8502
Mailing Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062
Business Address 5 REVERE DRIVE, SUITE 200 NORTHBROOK IL 60062 6143958936
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-283447 | Film No.: 17718316